Antiplatelet Removal and HemocompatIbility Events with the HeartMate

Recruiting

99 years or below

All

1 Location

Brief description of study

The HeartMate 3 requires medicines to keep your blood from clotting knowing as “blood thinners” which can both be anticoagulants and antiplatelet drugs. The standard drugs given when you have the HeartMate 3 are warfarin and aspirin. This study is investigating whether the combination of these drugs as compared to warfarin alone causes more bleeding without the benefit of preventing more blood clots.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Heart Failure
Age: 99 years or below
Gender: All

Subject will HeartMate

Updated on 04 Aug 2024. Study ID: 843216

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump

Brief description of study

Eligibility of study

Find a site

Interested in the study